NEWS
View news from our Featured Companies.
Zoomd Technologies to Participate in the 11th annual AlphaNorth Capital Event
TORONTO, Jan. 15, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, is pleased to announce the...
Zoomd’s Director and former CEO, Ofer Eitan, Establishes Automatic Share Disposition Plan
TORONTO, Jan. 14, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech) user-acquisition and engagement platform, announced today that Ofer Eitan, one...
Jewett-Cameron Reports Fiscal 2025 First Quarter Operational and Financial Results
NORTH PLAINS, Ore., Jan. 14, 2025 -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced operational and financial results for the fiscal 2025 first quarter for the period ended...
Bug Off Pest Control Center of New York City to Supply New York City with Evolve™
PHOENIX, Jan. 14, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in humane pest control solutions, is pleased to announce that Evolve™ Rodent Birth Control, our innovative rodent control product, will soon be available through...
S&W Seed Company Commencing Strategic Alternatives Review Process
LONGMONT, Colo., Jan. 13, 2025 -- S&W Seed Company (Nasdaq: SANW) ("S&W Seed" or the "Company"), today announced that its Board of Directors (the "Board") of the Company is commencing a process to explore and evaluate various strategic alternatives that may be...
NeurAxis Inc. Issues Letter to Shareholders
CARMEL, Ind., Jan. 13, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that CEO...
Zoomd Expands Global Reach with New Client Partnerships Across Multiple Industries
TORONTO, Jan. 13, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), a leading marketing tech (MarTech) user-acquisition and engagement platform, proudly announce the...
Joshua M. Moss Joining the SenesTech Board of Directors
PHOENIX, Jan. 10, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in humane pest control solutions, is pleased to announce that Joshua M. Moss will be joining the Board of Directors of SenesTech, Inc. Joshua M. Moss is the co-founder,...
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 revenue in the range of approximately $73.1 million to $73.3 millionIradimed is scheduled to present at the 43rd Annual J.P....
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
PORTLAND, Maine, Jan. 09, 2025 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Jewett-Cameron to Report Fiscal 2025 First Quarter Operational and Financial Results on January 14, 2025
NORTH PLAINS, Ore., Jan. 08, 2025 -- Jewett-Cameron Trading Company Ltd. ("Jewett-Cameron") (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, will report its operational and financial results for its fiscal 2025 first quarter,...
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
Revenues in 4Q24 increased approximately 50% versus 4Q23Cash balance as of 12/31/24 was approximately $3.7 million CARMEL, Ind., Jan. 08, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing...
ARIANNE PHOSPHATE PROVIDES 2024 RECAP AND DISCUSSES PLANS FOR 2025
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Jan. 8, 2025 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project...
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit
CUPERTINO, Calif., Jan. 07, 2025 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
CARMEL, Ind., Jan. 06, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that CEO...
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science of healthy aging, today announced that it will participate in a webcasted company presentation at the Lytham Partners 2025...
Greenfire Resources Announces Change of Control Offer to Purchase 12.000% Senior Secured Notes due 2028
Calgary, Alberta--(December 27, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Issuer") today announced that it has commenced a change of control offer (the "Change of Control Offer") relating to its outstanding 12.000% Senior Secured...
Greenfire Resources Announces Reconstitution of the Company’s Board of Directors, Acquisition of Additional Greenfire Securities by WEF and Continuation of the Strategic Review
Calgary, Alberta--(December 23, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), today announced a reconstitution of Greenfire’s Board of Directors (the “Board”), the termination of the amended and restated...
PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX to 800 Patients with a Concurrent Private Placement of up to $41 Million
630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025; Upon Potential Positive Phase 3 Data the Company Expects to Submit a New Drug Application ("NDA") for D-PLEX100 under Fast Track and Breakthrough...
S&W Secures New $25 Million Working Capital Facility
LONGMONT, Colo., Dec. 23, 2024 -- S&W Seed Company (Nasdaq: SANW) today announced it has closed a new $25 million revolving credit agreement with ABL OPCO LLC ("Mountain Ridge") which replaces an existing facility with CIBC Bank USA. In connection with the...
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
-Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CA /...
Jewett-Cameron Announces the Launch of the Adjust-A-Gate® Unlimited Low Profile Complete Gate Kit
A Flexible, Complete Solution for Professionals and DIY EnthusiastsNORTH PLAINS, Ore., Dec. 19, 2024 -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company dedicated to designing innovative products that enhance outdoor living, is proud to announce its...
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Dec. 19, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging ("MRI") compatible medical devices and the only provider of a non-magnetic intravenous ("IV") infusion pump system...
Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings
Lays out Phase 3 Clinical and Regulatory Path for Tecarfarin and Three-Year Strategic Plan PONTE VEDRA, Fla. - Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), announced today its engagement in three key events leading up to and during the 43rd Annual J.P. Morgan...
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants
CUPERTINO, Calif., Dec. 16, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...